Martina Kosikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martina Kosikova has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Hang Xie
Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, USA
5 shared publications - Marcela F. Pasetti
Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA
3 shared publications - Peter Radvak
Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD 20993, USA
3 shared publications - Carolyn M. Boudreau
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA
2 shared publications - Francesca J. Noelette
The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA
2 shared publications - Galit Alter
Ragon Institute of MGH, MIT, and Harvard, Cambridge, USA
2 shared publications
Latest Publications
- Open Access
- 8 April 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (4) , e0390425
Increased dose of H1N1 pandemic influenza vaccine during pregnancy improves immunity in mothers and infants
Maternal-infant immunity against influenza is improved through vaccination during pregnancy. We conducted an in-depth analysis of antibody (Ab) responses in sera from pregnant and non-pregnant women immunized with an unadjuvanted inactivated influenza A (H1N1) monovalent vaccine during the 2009 pandemic (NCT00992719). Pregnant women received either the standard 15 µg dose or the increased 30 µg dose, while non-pregnant women received the 15 µg dose. Ab specific for influenza hemagglutinin (HA), HA stalk, and neuraminidase (NA), as well as canonical functions of hemagglutination inhibition (HAI), microneutralization, and neuraminidase inhibition, was examined at baseline, 21 days post-vaccination, at delivery, and in cord blood. Ab subclasses, Fc receptor binding, and Fc-mediated immune functions, including cellular cytotoxicity, phagocytosis, and complement deposition, were also assessed. The vaccine was well tolerated and highly immunogenic in recipients; most participants had a ≥4-fold increase in Ab titers post-vaccination for HAI (HAI > 70%) and HA-specific IgG (IgG > 50%). Pregnant women who received the 15 µg dose had lower vaccine responses, as measured by NA-specific IgG, Fc receptor binding, and cell-mediated activity, compared with the other groups. Immunization of pregnant women with the 30 µg dose resulted in more robust humoral immunity, including a larger number of HA Ab features reaching 4-fold increases compared to the other groups, a more durable antiviral function, and increased NA-specific Ab features that were transferred to the infant as compared to pregnant women who received the standard 15 µg dose. Increasing the antigen content of seasonal vaccines could enhance immunity against influenza in mothers and infants and warrants further study. IMPORTANCE: Pregnant women and infants are at-risk groups for influenza infection. Vaccination is recommended during pregnancy to stimulate adaptive immunity and protect both the mother and infant early in life. We characterized the immune responses of pregnant and non-pregnant women to an unadjuvanted inactivated 2009 pandemic influenza A (H1N1). Pregnant women immunized with the 15 µg standard seasonal influenza vaccine dose developed lower NA-specific responses compared to non-pregnant women immunized with the same vaccine dose. Vaccination of pregnant women with a 30 µg dose resulted in more robust and durable post-vaccination responses, particularly longer-lasting functional antibodies and NA-specific antibodies in maternal and cord blood. A deeper analysis of antibody responses beyond the traditional hemagglutination inhibition (HAI) assay suggests that a higher-dose influenza vaccine, already recommended for the elderly, could be beneficial for pregnant women and warrants further investigation. CLINICAL TRIALS: This study is registered with ClinicalTrials.gov as NCT00992719 .
- 8 April 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (4) , e0390425
Open AccessIncreased dose of H1N1 pandemic influenza vaccine during pregnancy improves immunity in mothers and infants
Maternal-infant immunity against influenza is improved through vaccination during pregnancy. We conducted an in-depth analysis of antibody (Ab) responses in sera from pregnant and non-pregnant women immunized with an unadjuvanted inactivated influenza A (H1N1) monovalent vaccine during the 2009 pandemic (NCT00992719). Pregnant women received either the standard 15 µg dose or the increased 30 µg dose, while non-pregnant women received the 15 µg dose. Ab specific for influenza hemagglutinin (HA), HA stalk, and neuraminidase (NA), as well as canonical functions of hemagglutination inhibition (HAI), microneutralization, and neuraminidase inhibition, was examined at baseline, 21 days post-vaccination, at delivery, and in cord blood. Ab subclasses, Fc receptor binding, and Fc-mediated immune functions, including cellular cytotoxicity, phagocytosis, and complement deposition, were also assessed. The vaccine was well tolerated and highly immunogenic in recipients; most participants had a ≥4-fold increase in Ab titers post-vaccination for HAI (HAI > 70%) and HA-specific IgG (IgG > 50%). Pregnant women who received the 15 µg dose had lower vaccine responses, as measured by NA-specific IgG, Fc receptor binding, and cell-mediated activity, compared with the other groups. Immunization of pregnant women with the 30 µg dose resulted in more robust humoral immunity, including a larger number of HA Ab features reaching 4-fold increases compared to the other groups, a more durable antiviral function, and increased NA-specific Ab features that were transferred to the infant as compared to pregnant women who received the standard 15 µg dose. Increasing the antigen content of seasonal vaccines could enhance immunity against influenza in mothers and infants and warrants further study. IMPORTANCE: Pregnant women and infants are at-risk groups for influenza infection. Vaccination is recommended during pregnancy to stimulate adaptive immunity and protect both the mother and infant early in life. We characterized the immune responses of pregnant and non-pregnant women to an unadjuvanted inactivated 2009 pandemic influenza A (H1N1). Pregnant women immunized with the 15 µg standard seasonal influenza vaccine dose developed lower NA-specific responses compared to non-pregnant women immunized with the same vaccine dose. Vaccination of pregnant women with a 30 µg dose resulted in more robust and durable post-vaccination responses, particularly longer-lasting functional antibodies and NA-specific antibodies in maternal and cord blood. A deeper analysis of antibody responses beyond the traditional hemagglutination inhibition (HAI) assay suggests that a higher-dose influenza vaccine, already recommended for the elderly, could be beneficial for pregnant women and warrants further investigation. CLINICAL TRIALS: This study is registered with ClinicalTrials.gov as NCT00992719 .
- Open Access
- 31 March 2026
- Published by The London Academy of Science and Business Limited in Virtual Economics
- Vol. 9 (1) , 7-27
A New Perspective on Consumer Ethnocentrism and Its Selected Factors Using Ordinal Logistic Regression
Consumer ethnocentrism has become an increasingly important research topic in the era of digitalisation, which has accelerated globalisation, enhanced cultural openness, improved product traceability, and potentially reduced ethnocentric purchasing behaviour while reshaping its underlying determinants. This study aims to advance the understanding of consumer ethnocentrism, which, within an increasingly multicultural global society, represents an important area of research across marketing, business, sociology, psychology, and other social science disciplines. Specifically, the study investigates consumer ethnocentrism using the Consumer Ethnocentric Tendencies Scale (CETSCALE) and examines the effects of gender, generational cohort, and place of residence through ordinal logistic regression. Unlike conventional comparative approaches, ordinal logistic regression enables the estimation of response probabilities, thereby providing deeper insights into the relationships between socio-demographic characteristics and consumer ethnocentrism. In addition, the analysis is conducted at the level of individual CETSCALE statements rather than relying solely on aggregated scores, allowing for a more nuanced interpretation of respondents' attitudes. The empirical study is based on primary data collected from 491 respondents using a quota sampling design. The findings indicate that generational cohort and place of residence significantly influence selected dimensions of consumer ethnocentrism, whereas no statistically significant effect of gender was identified. Furthermore, several CETSCALE statements were evaluated almost identically across respondent groups, highlighting the importance of statement-level analysis. The findings have practical implications for marketing management, sociology, and consumer psychology. Keywords: consumer ethnocentrism, CETSCALE, ordinal logistic regression, factors of consumer ethnocentrism, globalization and digitalization barrier.
- 31 March 2026
- Published by The London Academy of Science and Business Limited in Virtual Economics
- Vol. 9 (1) , 7-27
Open AccessA New Perspective on Consumer Ethnocentrism and Its Selected Factors Using Ordinal Logistic Regression
Consumer ethnocentrism has become an increasingly important research topic in the era of digitalisation, which has accelerated globalisation, enhanced cultural openness, improved product traceability, and potentially reduced ethnocentric purchasing behaviour while reshaping its underlying determinants. This study aims to advance the understanding of consumer ethnocentrism, which, within an increasingly multicultural global society, represents an important area of research across marketing, business, sociology, psychology, and other social science disciplines. Specifically, the study investigates consumer ethnocentrism using the Consumer Ethnocentric Tendencies Scale (CETSCALE) and examines the effects of gender, generational cohort, and place of residence through ordinal logistic regression. Unlike conventional comparative approaches, ordinal logistic regression enables the estimation of response probabilities, thereby providing deeper insights into the relationships between socio-demographic characteristics and consumer ethnocentrism. In addition, the analysis is conducted at the level of individual CETSCALE statements rather than relying solely on aggregated scores, allowing for a more nuanced interpretation of respondents' attitudes. The empirical study is based on primary data collected from 491 respondents using a quota sampling design. The findings indicate that generational cohort and place of residence significantly influence selected dimensions of consumer ethnocentrism, whereas no statistically significant effect of gender was identified. Furthermore, several CETSCALE statements were evaluated almost identically across respondent groups, highlighting the importance of statement-level analysis. The findings have practical implications for marketing management, sociology, and consumer psychology. Keywords: consumer ethnocentrism, CETSCALE, ordinal logistic regression, factors of consumer ethnocentrism, globalization and digitalization barrier.
- Open Access
- 26 June 2025
- Published by College of Management, University of Information Technology and Management in Rzeszów in Financial Internet Quarterly
- Vol. 21 (2) , 89-104
EVALUATING ESG PRACTICES AND FINANCIAL IMPACTS: A COMPREHENSIVE ANALYSIS OF LEADING EUROPEAN ENTERPRISES UNDER CSR EUROPE\'S FRAMEWORK
This study investigates the integration and impact of Environmental, Social, and Governance (ESG) practices within large European enterprises from different industries affiliated with CSR Europe Initiative, which is an influential network championing sustainability. With the impending 2025 requirement for integrated annual reports combining ESG and financial disclosures under the Corporate Sustainability Reporting Directive (CSRD), this research evaluates how these enterprises adhere to and implement ESG principles in their operations. Focusing on a selected group of companies, including financial institutions governed by the Sustainable Finance Disclosure Regulation (SFDR), the study provides a detailed analysis of ESG behaviors using a structured set of seven criteria: Corporate Governance, Responsible Financing, Environmental Behavior, Social Behavior, Quality of Sustainability Reporting, Verification of Institutionalized ESG Strategy, and Annual Turnover. The results emphasize the pivotal influence of environmental strategies on revenue generation, while simultaneously uncovering significant disparities in ESG integration across firms. By addressing a critical gap in the literature regarding the financial implications of ESG engagement, the study contributes nuanced insights into how leading European corporations - specifically those affiliated with the CSR Europe Initiative - can strengthen their sustainability strategies and financial resilience. Furthermore, the findings underscore the necessity of a well-structured ESG framework not only for achieving long-term corporate sustainability, but also for ensuring alignment with evolving European Union regulatory requirements and stakeholder expectations.
- 26 June 2025
- Published by College of Management, University of Information Technology and Management in Rzeszów in Financial Internet Quarterly
- Vol. 21 (2) , 89-104
Open AccessEVALUATING ESG PRACTICES AND FINANCIAL IMPACTS: A COMPREHENSIVE ANALYSIS OF LEADING EUROPEAN ENTERPRISES UNDER CSR EUROPE\'S FRAMEWORK
This study investigates the integration and impact of Environmental, Social, and Governance (ESG) practices within large European enterprises from different industries affiliated with CSR Europe Initiative, which is an influential network championing sustainability. With the impending 2025 requirement for integrated annual reports combining ESG and financial disclosures under the Corporate Sustainability Reporting Directive (CSRD), this research evaluates how these enterprises adhere to and implement ESG principles in their operations. Focusing on a selected group of companies, including financial institutions governed by the Sustainable Finance Disclosure Regulation (SFDR), the study provides a detailed analysis of ESG behaviors using a structured set of seven criteria: Corporate Governance, Responsible Financing, Environmental Behavior, Social Behavior, Quality of Sustainability Reporting, Verification of Institutionalized ESG Strategy, and Annual Turnover. The results emphasize the pivotal influence of environmental strategies on revenue generation, while simultaneously uncovering significant disparities in ESG integration across firms. By addressing a critical gap in the literature regarding the financial implications of ESG engagement, the study contributes nuanced insights into how leading European corporations - specifically those affiliated with the CSR Europe Initiative - can strengthen their sustainability strategies and financial resilience. Furthermore, the findings underscore the necessity of a well-structured ESG framework not only for achieving long-term corporate sustainability, but also for ensuring alignment with evolving European Union regulatory requirements and stakeholder expectations.
- Open Access
- 28 October 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (21) , 15705
Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
COVID-19 has highlighted challenges in the measurement quality and comparability of serological binding and neutralization assays. Due to many different assay formats and reagents, these measurements are known to be highly variable with large uncertainties. The development of the WHO international standard (WHO IS) and other pool standards have facilitated assay comparability through normalization to a common material but does not provide assay harmonization nor uncertainty quantification. In this paper, we present the results from an interlaboratory study that led to the development of (1) a novel hierarchy of data analyses based on the thermodynamics of antibody binding and (2) a modeling framework that quantifies the probability of neutralization potential for a given binding measurement. Importantly, we introduced a precise, mathematical definition of harmonization that separates the sources of quantitative uncertainties, some of which can be corrected to enable, for the first time, assay comparability. Both the theory and experimental data confirmed that mAbs and WHO IS performed identically as a primary standard for establishing traceability and bridging across different assay platforms. The metrological anchoring of complex serological binding and neuralization assays and fast turn-around production of an mAb reference control can enable the unprecedented comparability and traceability of serological binding assay results for new variants of SARS-CoV-2 and immune responses to other viruses.
- 28 October 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (21) , 15705
Open AccessMonoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
COVID-19 has highlighted challenges in the measurement quality and comparability of serological binding and neutralization assays. Due to many different assay formats and reagents, these measurements are known to be highly variable with large uncertainties. The development of the WHO international standard (WHO IS) and other pool standards have facilitated assay comparability through normalization to a common material but does not provide assay harmonization nor uncertainty quantification. In this paper, we present the results from an interlaboratory study that led to the development of (1) a novel hierarchy of data analyses based on the thermodynamics of antibody binding and (2) a modeling framework that quantifies the probability of neutralization potential for a given binding measurement. Importantly, we introduced a precise, mathematical definition of harmonization that separates the sources of quantitative uncertainties, some of which can be corrected to enable, for the first time, assay comparability. Both the theory and experimental data confirmed that mAbs and WHO IS performed identically as a primary standard for establishing traceability and bridging across different assay platforms. The metrological anchoring of complex serological binding and neuralization assays and fast turn-around production of an mAb reference control can enable the unprecedented comparability and traceability of serological binding assay results for new variants of SARS-CoV-2 and immune responses to other viruses.
- Open Access
Mapping the Antibody Repertoires in Ferrets with Repeated Influenza A/H3 Infections: Is Original Antigenic Sin Really “Sinful”?
The influenza-specific antibody repertoire is continuously reshaped by infection and vaccination. The host immune response to contemporary viruses can be redirected to preferentially boost antibodies specific for viruses encountered early in life, a phenomenon called original antigenic sin (OAS) that is suggested to be responsible for diminished vaccine effectiveness after repeated seasonal vaccination. Using a new computational tool called Neutralization Landscapes, we tracked the progression of hemagglutination inhibition antibodies within ferret antisera elicited by repeated influenza A/H3 infections and deciphered the influence of prior exposures on the de novo antibody response to evolved viruses. The results indicate that a broadly neutralizing antibody signature can nevertheless be induced by repeated exposures despite OAS induction. Our study offers a new way to visualize how immune history shapes individual antibodies within a repertoire, which may help to inform future universal influenza vaccine design.
Open AccessMapping the Antibody Repertoires in Ferrets with Repeated Influenza A/H3 Infections: Is Original Antigenic Sin Really “Sinful”?
The influenza-specific antibody repertoire is continuously reshaped by infection and vaccination. The host immune response to contemporary viruses can be redirected to preferentially boost antibodies specific for viruses encountered early in life, a phenomenon called original antigenic sin (OAS) that is suggested to be responsible for diminished vaccine effectiveness after repeated seasonal vaccination. Using a new computational tool called Neutralization Landscapes, we tracked the progression of hemagglutination inhibition antibodies within ferret antisera elicited by repeated influenza A/H3 infections and deciphered the influence of prior exposures on the de novo antibody response to evolved viruses. The results indicate that a broadly neutralizing antibody signature can nevertheless be induced by repeated exposures despite OAS induction. Our study offers a new way to visualize how immune history shapes individual antibodies within a repertoire, which may help to inform future universal influenza vaccine design.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Functional and Structural Modifications of Influenza Antibodies During Pregnancy
Pregnancy represents a unique tolerogenic immune state which may alter susceptibility to infection and vaccine-response. Here we characterized humoral immunity to seasonal influenza vaccine strains in pregnant and non-pregnant women. Pregnant women had reduced hemagglutinin subtype-1 (H1)- IgG, IgG1, and IgG2, hemagglutination inhibition and group 1 and 2 stem IgG. However, H1-specific avidity and FcγR1 binding increased. Influenza-antibodies in pregnancy had distinct Fc and Fab glycans characterized by di-galactosylation and di-sialylation. In contrast, agalactosylation and bisection were prominent outside of pregnancy. H1-specific Fc-functionality was moderately reduced in pregnancy, although likely compensated by stronger binding to cognate antigen and FcR. Multivariate analysis revealed distinct populations characterized by FcγR1 binding, H1-IgG levels, and glycosylation. Pooled sera from pregnant women exhibited longer retention in vivo. Our results demonstrate structural and functional modulation of humoral immunity during pregnancy in an antigen-specific manner towards reduced inflammation, increased retention in circulation, and efficient placental transport.
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessFunctional and Structural Modifications of Influenza Antibodies During Pregnancy
Pregnancy represents a unique tolerogenic immune state which may alter susceptibility to infection and vaccine-response. Here we characterized humoral immunity to seasonal influenza vaccine strains in pregnant and non-pregnant women. Pregnant women had reduced hemagglutinin subtype-1 (H1)- IgG, IgG1, and IgG2, hemagglutination inhibition and group 1 and 2 stem IgG. However, H1-specific avidity and FcγR1 binding increased. Influenza-antibodies in pregnancy had distinct Fc and Fab glycans characterized by di-galactosylation and di-sialylation. In contrast, agalactosylation and bisection were prominent outside of pregnancy. H1-specific Fc-functionality was moderately reduced in pregnancy, although likely compensated by stronger binding to cognate antigen and FcR. Multivariate analysis revealed distinct populations characterized by FcγR1 binding, H1-IgG levels, and glycosylation. Pooled sera from pregnant women exhibited longer retention in vivo. Our results demonstrate structural and functional modulation of humoral immunity during pregnancy in an antigen-specific manner towards reduced inflammation, increased retention in circulation, and efficient placental transport.
- Open Access
- 18 January 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (1) , e1006796
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs
Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in human populations despite widespread herd immunity. Understanding viral mechanisms that enable antigenic evolution is critical for designing durable vaccines and therapeutics. Here, we utilize the primerID method of error-correcting viral population sequencing to reveal an unexpected role for hemagglutinin (HA) glycosylation in compensating for fitness defects resulting from escape from anti-HA neutralizing antibodies. Antibody-free propagation following antigenic escape rapidly selected viruses with mutations that modulated receptor binding avidity through the addition of N-linked glycans to the HA globular domain. These findings expand our understanding of the viral mechanisms that maintain fitness during antigenic evolution to include glycan addition, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms. Seasonal influenza A viruses (IAV) cause tens of thousands of deaths and tens of billions of dollars in economic costs every year in the U.S. alone, despite widespread pre-exposure and vaccination. IAV persists within the human population by evading herd immunity through the continual accumulation of immune escape substitutions in a process known as antigenic drift. Unfortunately, the specific mechanisms that facilitate IAV antigenic drift remain unclear, making it difficult to design more efficacious, escape-proof vaccines. Here, we used a high-definition population sequencing approach to understand how IAV tolerates the accumulation of immune escape substitutions during antigenic drift without losing fitness. We found that the virus rapidly acquired N-linked glycan structures on the hemagglutinin (HA) protein following escape from a panel of neutralizing antibodies. Glycosylation of HA alleviated the deleterious effects of immune escape substitutions on interactions with host cell receptors. These results expand our understanding of the mechanisms that facilitate IAV immune evasion, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms.
- 18 January 2018
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 14 (1) , e1006796
Open AccessInfluenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs
Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in human populations despite widespread herd immunity. Understanding viral mechanisms that enable antigenic evolution is critical for designing durable vaccines and therapeutics. Here, we utilize the primerID method of error-correcting viral population sequencing to reveal an unexpected role for hemagglutinin (HA) glycosylation in compensating for fitness defects resulting from escape from anti-HA neutralizing antibodies. Antibody-free propagation following antigenic escape rapidly selected viruses with mutations that modulated receptor binding avidity through the addition of N-linked glycans to the HA globular domain. These findings expand our understanding of the viral mechanisms that maintain fitness during antigenic evolution to include glycan addition, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms. Seasonal influenza A viruses (IAV) cause tens of thousands of deaths and tens of billions of dollars in economic costs every year in the U.S. alone, despite widespread pre-exposure and vaccination. IAV persists within the human population by evading herd immunity through the continual accumulation of immune escape substitutions in a process known as antigenic drift. Unfortunately, the specific mechanisms that facilitate IAV antigenic drift remain unclear, making it difficult to design more efficacious, escape-proof vaccines. Here, we used a high-definition population sequencing approach to understand how IAV tolerates the accumulation of immune escape substitutions during antigenic drift without losing fitness. We found that the virus rapidly acquired N-linked glycan structures on the hemagglutinin (HA) protein following escape from a panel of neutralizing antibodies. Glycosylation of HA alleviated the deleterious effects of immune escape substitutions on interactions with host cell receptors. These results expand our understanding of the mechanisms that facilitate IAV immune evasion, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms.